Indian oncology hospital group HealhCare Global Enterprises (HCG) has sold its minority stake in life sciences company Strand after buying in full its oncology lab and clinical trials business.
UK hospital group Spire Healthcare's revenue in H1 2021 jumped 13.5% versus 2019, with self-pay up a whopping 47%. But profitability was still lower than two years ago and, despite the top-line growth eclipsing guidance, the group is still trading well below Ramsay's improved offer price that 30% of shareholders rejected. Will they regret that?
Around 5% of healthcare workers in Greece's private hospital sector have been suspended after the state made COVID-19 jabs mandatory, an operator tells HBI.
As expected, M&A deal flow slowed through August as bankers and executives headed out on summer vacations. HBI has caught up with the mid-to-small-cap deals you may have missed; featuring hospitals, ophthalmology, and homecare.
Hungarian billionaire Sándor Csányi has bought out the remaining 25% equity of Buda Health Center, Hungary's second-largest private acute care operator by revenue, from its founder. The new ownership is set on completing the construction of a new inpatient block.
Apollo Hospitals, India's largest hospital group by revenue, has spun off its pharmacy and digital business into a new subsidiary and appointed banks to sell a 15-20% stake. Amazon was considering a $100m stake in the division at the end of last year as India's online pharmacy sector continues to see a glut of investment with rival PharmEasy also targeting a $9bn IPO.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
